106 related articles for article (PubMed ID: 1337377)
1. Differential effect of arachidonic acid on the vasoactive intestinal peptide receptor/effector system in rat prostatic epithelium during sexual maturation.
Carmena MJ; Hueso C; Solano RM; Prieto JC
Peptides; 1992; 13(6):1117-22. PubMed ID: 1337377
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol modulation of membrane fluidity and VIP receptor/effector system in rat prostatic epithelial cells.
Carmena MJ; Hueso C; Guijarro LG; Prieto JC
Regul Pept; 1991 May; 33(3):287-97. PubMed ID: 1652781
[TBL] [Abstract][Full Text] [Related]
3. Effects of age and androgens upon functional vasoactive intestinal peptide receptors in rat prostatic epithelial cells.
Carmena MJ; Sancho JI; Prieto JC
Biochim Biophys Acta; 1986 Oct; 888(3):338-43. PubMed ID: 3019425
[TBL] [Abstract][Full Text] [Related]
4. Influence of castration and testosterone treatment on the vasoactive intestinal peptide receptor/effector system in rat prostatic epithelial cells.
Carmena MJ; Recio MN; Prieto JC
Biochim Biophys Acta; 1988 Apr; 969(1):86-90. PubMed ID: 2832001
[TBL] [Abstract][Full Text] [Related]
5. Tumor-promoting phorbol esters interfere with the vasoactive intestinal peptide receptor/effector system in rat prostatic epithelial cells.
Escudero F; Carmena MJ; Prieto JC
Biochem Biophys Res Commun; 1987 Nov; 149(1):221-6. PubMed ID: 2825698
[TBL] [Abstract][Full Text] [Related]
6. Effect of gastroduodenostomy on intestinal vasoactive intestinal peptide (VIP) levels, and VIP binding and VIP stimulation of cyclic AMP in intestinal epithelial cells from rat.
Carmena MJ; Prieto JC; Arilla E; Cacicedo L
Biochem Med Metab Biol; 1987 Jun; 37(3):307-13. PubMed ID: 2440464
[TBL] [Abstract][Full Text] [Related]
7. The vasoactive intestinal peptide receptor-effector system is developmentally regulated in rat jejuno-ileal epithelial cells.
Fernandez-Moreno MD; Diaz-Juarez JL; Fernandez-Gonzalez MA; Sanchez-Franco F; Prieto JC
Biochem Int; 1988 Feb; 16(2):331-7. PubMed ID: 2835052
[TBL] [Abstract][Full Text] [Related]
8. Lindane effect upon the vasoactive intestinal peptide receptor/effector system in rat enterocytes.
Carrero I; Fernández-Moreno MD; Pérez-Albarsanz MA; Prieto JC
Biochem Biophys Res Commun; 1989 Mar; 159(3):1391-6. PubMed ID: 2467674
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of the arachidonic acid cascade on the alpha 1-adrenergic potentiation of vasoactive intestinal peptide- versus beta-adrenergic-stimulated cyclic AMP and cyclic GMP accumulation in rat pinealocytes.
Chik CL; Young I; Ho AK
J Neurochem; 1991 Nov; 57(5):1534-9. PubMed ID: 1655977
[TBL] [Abstract][Full Text] [Related]
10. Interaction between catecholamines and vasoactive intestinal peptide in cultured astrocytes.
Hansson E; Rönnbäck L
Neuropharmacology; 1988 Mar; 27(3):295-300. PubMed ID: 2836754
[TBL] [Abstract][Full Text] [Related]
11. Effect of bilateral adrenalectomy on VIP receptor/effector system in rat intestinal epithelial cells.
Fernández-Moreno MD; Carrero I; Arilla E; Prieto JC
Biosci Rep; 1990 Apr; 10(2):165-71. PubMed ID: 2162701
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of VIP or isoproterenol on forskolin-stimulated cyclic AMP accumulation in rat prostatic epithelial cells.
Carmena MJ; Sancho JI; Prieto JC
Biochem Int; 1986 Sep; 13(3):479-85. PubMed ID: 3024642
[TBL] [Abstract][Full Text] [Related]
13. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
Chastre E; Emami S; Rosselin G; Gespach C
Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
[TBL] [Abstract][Full Text] [Related]
14. Ileal vasoactive intestinal peptide (VIP) levels and VIP receptor/effector system in ileal epithelial cells after colectomy in the rat.
Fernandez-Moreno MD; Fernandez-Gonzalez MA; Arilla E; Lorenzo MJ; Prieto JC
Biochem Med Metab Biol; 1987 Oct; 38(2):213-8. PubMed ID: 2823853
[TBL] [Abstract][Full Text] [Related]
15. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
Gozes I; McCune SK; Jacobson L; Warren D; Moody TW; Fridkin M; Brenneman DE
J Pharmacol Exp Ther; 1991 Jun; 257(3):959-66. PubMed ID: 1646331
[TBL] [Abstract][Full Text] [Related]
16. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin inhibits VIP- and isoproterenol-stimulated cyclic AMP accumulation in rat prostatic epithelial cells.
Carmena MJ; Sancho JI; Fernández-González MA; Escudero F; Prieto JC
FEBS Lett; 1987 Jun; 218(1):73-6. PubMed ID: 2885224
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
19. Decreased binding of vasoactive intestinal peptide to intestinal epithelial cells from hypothyroid rats.
Molinero P; Calvo JR; Jimenez J; Goberna R; Guerrero JM
Biochem Biophys Res Commun; 1989 Jul; 162(2):701-7. PubMed ID: 2547371
[TBL] [Abstract][Full Text] [Related]
20. Effect of intestinal ischaemia on intestinal VIP levels and VIP interaction with intestinal epithelial cells from rat.
Fernández-Moreno MD; Arilla E; Prieto JC
Comp Biochem Physiol A Comp Physiol; 1989; 93(2):463-6. PubMed ID: 2573460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
